US › Healthcare

Allurion Technologies, Inc. (ALUR)

US · Healthcare · Medical Devices

$4.98+5.62%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.9M

Revenue YoY

-47.2%

Net profit

$-6.1M

Profit YoY

-306.1%

EPS

$-6.90

EPS estimate

$-5.10

Net margin

-206.8%

EPS came in at -6.90 against a street estimate of -5.10 — a miss of 35.3%.

Key statistics

Market cap

$4.0M

Forward P/E

1.0

P/B

0.00

Book value

$-5.20

EPS (TTM)

$-3.96

52-week high

$43.49

52-week low

$2.67

50-day MA

$10.37

200-day MA

$17.98

Beta

-0.17

Analyst view

Analysts rate Allurion Technologies, Inc. a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $82.50.

Shareholding

Insiders

5.18%

Institutions

1.18%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Allurion Technologies, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.